脂蛋白对重症监护病房患者进展为慢性危重症的预测价值
该回顾性队列研究纳入南京鼓楼医院ICU 2020年1月1日至2022年12月31日收治的200例患者,分析入ICU后1、3、7、14、21天HDL、LDL、ApoA-I、ApoB水平与进展为CCI(ICU住院≥14天且SOFA评分≥2)的关系。137例(68.5%)进展为CCI,CCI组脂蛋白在急性期后下降而非CCI组上升,各时间点HDL、LDL、ApoA-I、ApoB均显著低于非CCI组,7天HDL差异最明显。多因素Logistic回归显示7天HDL是进展为CCI的独立危险因素(OR=0.033,95%CI 0.004-0.282,P=0.002),ROC曲线AUC为0.702(95%CI 0.625-0.779,P<0.001),最佳截断值0.59 mmol/L时敏感度69.8%、特异度72.4%。结论认为低脂蛋白水平与重症患者病情进展密切相关,动态观察脂蛋白变化趋势有助于判断CCI进展。
要点
- 7天HDL是重症患者进展为CCI的独立危险因素,OR=0.033(95%CI 0.004-0.282,P=0.002)。
- 7天HDL预测CCI的AUC为0.702(95%CI 0.625-0.779,P<0.001),截断值0.59 mmol/L时敏感度69.8%、特异度72.4%。
- CCI组7天HDL显著低于非CCI组[0.44(0.31,0.61)mmol/L vs. 0.67(0.49,0.75)mmol/L,P<0.01]。
- CCI组脂蛋白在急性期后下降,非CCI组上升;各时间点HDL、LDL、ApoA-I、ApoB均显著低于非CCI组。
- 200例中137例(68.5%)进展为CCI,63例(31.5%)未进展。
适用人群与场景
- 南京鼓楼医院ICU 2020年1月1日至2022年12月31日收治的危重症患者,最终纳入200例进行分析。
- 按是否进展为CCI分为CCI组137例(68.5%)和非CCI组63例(31.5%)。
诊断标准与关键阈值
- CCI定义:ICU住院时间≥14天且持续器官功能障碍[序贯器官衰竭评估(SOFA)评分≥2]。
- 7天HDL预测CCI的最佳截断值为0.59 mmol/L,敏感度69.8%,特异度72.4%。
研究设计与关键结果
- 研究类型:回顾性队列研究,样本量200例,单中心(南京鼓楼医院ICU),人群为ICU危重症患者。
- 暴露/观察指标:入ICU后1、3、7、14、21天HDL、LDL、ApoA-I、ApoB水平;主要终点为进展为CCI。
- CCI组脂蛋白在急性期后下降,非CCI组上升;CCI组各时间点HDL、LDL、ApoA-I、ApoB均显著低于非CCI组。
- 7天HDL:CCI组0.44(0.31,0.61)mmol/L vs. 非CCI组0.67(0.49,0.75)mmol/L,P<0.01。
- 多因素Logistic回归:7天HDL为进展为CCI的独立危险因素,OR=0.033(95%CI 0.004-0.282),P=0.002。
- ROC曲线:7天HDL预测CCI的AUC=0.702(95%CI 0.625-0.779),P<0.001;截断值0.59 mmol/L时敏感度69.8%、特异度72.4%。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为低脂蛋白水平与重症患者病情进展密切相关。
- 作者认为7天HDL对重症患者进展为CCI有一定预测价值。
- 作者认为持续观察脂蛋白水平变化趋势有助于判断重症患者CCI进展。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the predictive value of lipoproteins on the progression of critically ill patients to chronic critical illness (CCI).
METHODS: A retrospective cohort study was conducted to analyze clinical data of patients admitted to the intensive care unit (ICU) of Nanjing Drum Tower Hospital from January 1, 2020, to December 31, 2022. The levels of high-density lipoprotein (HDL), low-density lipoprotein (LDL) and apolipoproteins (ApoA-I, ApoB) at 1, 3, 7, 14 and 21 days after admission to ICU were collected. The progression to CCI was recorded. CCI was defined as the length of ICU stay ≥14 days with sustained organ dysfunction [sequential organ failure assessment (SOFA) score ≥2]. Differences in lipoprotein levels between the patients with and without CCI were compared. Multivariate Logistic regression was used to analyze risk factors for critically ill patients progressing to CCI. Receiver operator characteristic curve (ROC curve) was drawn to evaluate the predictive value of lipoproteins on critically ill patients progressing to CCI.
RESULTS: A total of 200 patients were enrolled in the final analysis. 137 patients (68.5%) progressed to CCI, and 63 patients (31.5%) did not. The lipoprotein indicators in the CCI group showed a decrease after the acute phase, while the lipoprotein indicators in the non-CCI group showed an increase. The levels of HDL, LDL, ApoA-I, and ApoB at various time points in the CCI group were significantly lower than those in the non-CCI group. HDL at 7 days in the CCI group was significantly lower than that in the non-CCI group [mmol/L: 0.44 (0.31, 0.61) vs. 0.67 (0.49, 0.75), P < 0.01]. Multivariate Logistic regression analysis showed that 7-day HDL was an independent risk factor for critically ill patients progressing to CCI [odds ratio (OR) = 0.033, 95% confidence interval (95%CI) was 0.004-0.282, P = 0.002]. ROC curve analysis showed that the area under the ROC curve (AUC) of 7-day HDL for predicting critically ill patients progressing to CCI was 0.702, with a 95%CI of 0.625-0.779, P < 0.001. When the optimal cut-off value was 0.59 mmol/L, the sensitivity was 69.8%, and the specificity was 72.4%.
CONCLUSIONS: The low level of lipoproteins is closely related to the progression of critically ill patients, and 7-day HDL has a certain predictive value for critically ill patients progressing to CCI. Continuously observation of the change trend of lipoprotein level is helpful to judge the progression of CCI in critically ill patients.
参考来源
- Huang S, Chen X, Chen M, et al. [Predictive value of lipoproteins on progression to chronic critical illness in intensive care unit patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38404277. doi:10.3760/cma.j.cn121430-20230610-00432
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。